| Financial Year |
March 31 2023 |
| Monetary Funds |
564,975,004.64 |
| Held-for-trading Financial Assets |
30,524,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
478,222.59 |
| Advances to Suppliers |
14,677,204.82 |
| Other Receivables |
1,619,036.60 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
286,245,746.08 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
20,051,277.78 |
| Other Current Assets |
89,177,594.43 |
| Total Current Assets |
1,007,748,086.94 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
23,932,102.00 |
| Fixed Assetes |
675,491,589.15 |
| Under-construction Projects |
230,113,668.82 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
138,892,177.53 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
22,484,448.81 |
| Other Non-Current Assets |
346,067,437.68 |
| Sub-Total of Non-Current Assets |
1,437,516,427.48 |
| Total Assets |
2,445,264,514.42 |
| Short-Term Loans |
75,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
84,576,050.03 |
| Accounts Payable |
246,398,671.16 |
| Accounts Received In Advance |
47,079.96 |
| Employee Compensation Payable |
16,473,829.44 |
| Taxes Payable |
57,429,420.96 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
46,755,469.09 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
2,852,616.44 |
| Sub-Total of Current Liabilities |
576,289,623.33 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
131,000.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
80,877,523.44 |
| Total Liabilities |
657,167,146.77 |
| Paid-In Capital(Or Share Stock) |
303,408,000.00 |
| Capital Surplus |
660,156,477.93 |
| Surplus Reserve |
63,952,589.07 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
760,580,300.65 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,788,097,367.65 |
| Owner's Equity（Stockholder's Equity） |
1,788,097,367.65 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,445,264,514.42 |
